BruceBlaus

Benign and Malignant Digestive System Tumors

Article
Digestive Health
Diseases & Conditions
+2
Contributed byKrish Tangella MD, MBANov 01, 2023

Digestive system tumors can either be benign (non-cancerous) or malignant (cancerous). There are certain tumors that are classified as atypical (uncertain or unspecified behavior) meaning that some behave in a benign manner, or some behave in a malignant manner. A majority of the tumors diagnosed via lab studies (biopsy) are benign.

Tumors of the digestive system may involve the anatomical regions of esophagus, stomach, small intestine and ampulla, appendix, colon and rectum, liver and intrahepatic bile ducts, gallbladder and extrahepatic bile ducts, pancreas, and the anal canal.

The World Health Organization (WHO) is an authoritative body that compiles, prepares, and publishes histological and molecular classification of tumors, via their Blue Books, based on research inputs from experts worldwide. These reference books chiefly aid in global cancer research, provide gold standards for tumor diagnosis, and help in treating cancer patients.

According to the WHO Classification of Digestive System Tumors (2019), 5th Ed., Vol. 1, benign and malignant tumors of the digestive system are classified in the following manner:

Tumors of the esophagus:

Tumors of the esophagus

Epithelial tumors

Tumors of the stomach:

Tumors of the stomach

Gastritis and metaplasia: precursors of gastric neoplasms

Epithelial tumors

Tumors of the small intestine and ampulla:

Tumors of the small intestine and ampulla

Epithelial tumors

  • Benign epithelial tumors and precursors
  • Malignant epithelial tumors
    • Non-ampullary adenocarcinoma
    • Ampullary adenocarcinoma
    • Small intestinal and ampullary neuroendocrine neoplasms

Tumors of the appendix:

Tumors of the appendix

Epithelial tumors

  • Appendiceal serrated lesions and polyps
  • Appendiceal mucinous neoplasm
  • Appendiceal adenocarcinoma
  • Appendiceal goblet cell adenocarcinoma
  • Appendiceal neuroendocrine neoplasms

Tumors of the colon and rectum:

Tumors of the colon and rectum

Epithelial tumors

Tumors of the anal canal:

Tumors of the anal canal

Epithelial tumors

  • Benign epithelial tumors and precursors
    • Inflammatory cloacogenic polyp
    • Anal condyloma
    • Anal squamous dysplasia (intraepithelial neoplasia)
  • Malignant epithelial tumors

Tumors of the liver and intrahepatic bile ducts:

Tumors of the liver and intrahepatic bile ducts

Epithelial tumors

  • Benign hepatocellular tumors
  • Malignant hepatocellular tumors and precursors
  • Benign biliary tumors and precursors
    • Bile duct adenoma
    • Biliary adenofibroma
    • Biliary intraepithelial neoplasia
    • Intraductal papillary neoplasm of the bile ducts
    • Mucinous cystic neoplasm of the liver and biliary system
  • Malignant biliary tumors
    • Intrahepatic cholangiocarcinoma
  • Combined hepatocellular-cholangiocarcinoma and undifferentiated primary liver carcinoma
  • Hepatic neuroendocrine neoplasms

Tumors of the gallbladder and extrahepatic bile ducts:

Tumors of the gallbladder and extrahepatic bile ducts

Epithelial tumors

  • Benign epithelial tumors and precursors
    • Pyloric gland adenoma of the gallbladder
    • Biliary intraepithelial neoplasia
    • Intracholecystic papillary neoplasm (formerly Intracystic / intraductal papillary neoplasm)
    • Intraductal papillary neoplasm of the bile ducts
  • Malignant epithelial tumors
    • Carcinoma of the gallbladder
    • Carcinoma of the extrahepatic bile ducts
    • Neuroendocrine neoplasms of the gallbladder and bile ducts

Tumors of the pancreas:

Tumors of the pancreas

Epithelial tumors

Hematolymphoid tumors of the digestive system:

Hematolymphoid tumors of the digestive system

Hematolymphoid tumors

  • Site-specific hematolymphoid tumors
    • Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) involving the digestive tract
    • Duodenal-type follicular lymphoma
    • Enteropathy-associated T-cell lymphoma: It is a T-cell non-Hodgkin’s lymphoma of the gastrointestinal tract. It is a rare and aggressive malignancy of T-cell lymphocytes arising in the intestines. It is noted in middle-aged and older adults
    • Monomorphic epitheliotropic intestinal T-cell lymphoma
    • Intestinal T-cell lymphoma NOS
    • Indolent T-cell lymphoproliferative disorder of the GI tract
    • Hepatosplenic T-cell lymphoma: It is an extremely rare and aggressive type of ‘extranodal lymphoma’ observed in the spleen, liver, and bone marrow. It is most commonly seen in adolescents  and young adults
    • EBV+ inflammatory follicular dendritic cell sarcoma of the digestive tract
  • Hematolymphoid tumors occurring with some frequency in the digestive system
    • Diffuse large B-cell lymphoma
    • Follicular lymphoma: Gastrointestinal Follicular Lymphoma (GI-FL) is a rare type of B-cell non-Hodgkin’s lymphoma that generally affects older adults. It is typically a low-grade malignancy lymphoma
    • Mantle cell lymphoma
    • Burkitt lymphoma
    • Plasmablastic lymphoma
    • Posttransplant lymphoproliferative disorders
    • Extranodal NK/T-cell lymphoma
    • Systemic mastocytosis
    • Langerhans cell histiocytosis: It is a rare, complicated, and non-heritable genetic disorder that can result in tumor formation in many different body parts. The disorder typically affects very young children
    • Follicular dendritic cell sarcoma
    • Histiocytic sarcoma

Mesenchymal tumors of the digestive system:

Mesenchymal tumors of the digestive system

Mesenchymal tumors

  • Gastrointestinal stromal tumor
    • Gastrointestinal stromal tumor: It is a type of tumor that occurs in the gastrointestinal tract. The most common location of this tumor is the stomach, or the small intestine. The tumor usually forms in adults
  • Adipose tissue and (myo)fibroblastic tumors
    • Inflammatory myofibroblastic tumor
    • Desmoid fibromatosis
    • Solitary fibrous tumor
    • Lipoma
    • Inflammatory fibroid polyp
    • Plexiform fibromyxoma
  • Smooth muscle and skeletal muscle tumors
    • Leiomyoma
    • Leiomyosarcoma
    • Rhabdomyosarcoma
  • Vascular and perivascular tumors
    • Hemangioma
    • Epithelioid hemangioendothelioma (prev Vascular Tumors in Liver)
    • Kaposi sarcoma
    • Angiosarcoma
    • Glomus tumor
    • Lymphangioma and lymphangiomatosis
  • Neural tumors
    • Schwannoma
    • Granular cell tumor
    • Perineurioma: Gastrointestinal (GI) Tract Perineurioma is a rare tumor that affects middle-aged and older women. It usually occurs in the left colon (large intestine) and rectum. The tumor usually occurs in adult women
    • Ganglioneuroma and ganglioneuromatosis
  • Tumors of uncertain differentiation
    • PEComa, including angiomyolipoma
    • Mesenchymal hamartoma of the liver
    • Calcifying nested stromal-epithelial tumor of the liver
    • Synovial sarcoma
    • Gastrointestinal clear cell sarcoma / malignant gastrointestinal neuroectodermal tumor
    • Embryonal sarcoma of the liver

Other tumors of the digestive system:

  • Other tumors of the digestive system
    • Mucosal melanoma of the digestive system
    • Germ cell tumors of the digestive system
    • Digestive system metastases


Genetic tumor syndromes of the digestive system:

Genetic tumor syndromes of the digestive system

Genetics

  • Genetic tumor syndromes of the digestive system
    • Lynch syndrome: It is an inherited syndrome wherein there are increased malignancy of the gastrointestinal tract, particularly in the colon and rectum. The average age of colon cancer diagnosis in those with Lynch Syndrome is 44 years
    • Familial adenomatous polyposis 1
    • GAPPS and other fundic gland polyposes
    • Other adenomatous polyposes
    • Serrated polyposis
    • Hereditary diffuse gastric cancer
    • Familial pancreatic cancer
    • Juvenile polyposis syndrome: It is a disorder characterized by multiple hamartomatous benign growths or polyps, usually in large intestines. It is a rare congenital disorder with symptom onset in the second decade
    • Peutz-Jeghers syndrome: It is a rare autosomal dominant condition that increases one’s susceptibility to developing polyps and certain malignancy types; polyp formation is observed into adolescence and young adulthood
    • Cowden syndrome: It is an inherited condition that is characterized primarily by multiple, noncancerous growths, known as hamartomas, on various parts of the body. It is known to present symptoms during early adulthood
    • Other genetic tumor syndromes


Additional digestive system tumor articles (on DoveMed) that are not part of WHO Classification of Digestive System Tumors:

Digestive System Melanoma: It refers to a melanoma starting in the stomach, intestines, salivary glands, mouth, esophagus, liver, pancreas, gallbladder, or rectum. It is a rare condition that may affect individuals of all ages.

Rosai-Dorfman Disease of Digestive System: It is an extremely rare extranodal form of Rosai-Dorfman disease, wherein along-with involvement of the lymph nodes, the gastrointestinal tract including the liver, spleen, gallbladder, and pancreas is also affected. It is a very rare condition that may affect children and adults.

Was this article helpful

On the Article

Krish Tangella MD, MBA picture
Approved by

Krish Tangella MD, MBA

Pathology, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!